On Invalid Date, Unity Biotechnology (NASDAQ: UBX) reported Q4 2023 earnings per share (EPS) of -$0.04, up 103.67% year over year. Total Unity Biotechnology earnings for the quarter were -$1.50 million. In the same quarter last year, Unity Biotechnology's earnings per share (EPS) was $1.09.
As of Q2 2024, Unity Biotechnology's earnings has grown year over year. Unity Biotechnology's earnings in the past year totalled -$39.86 million.
What is UBX's earnings date?
Unity Biotechnology's earnings date is Invalid Date. Add UBX to your watchlist to be reminded of UBX's next earnings announcement.
What was UBX's revenue last quarter?
On Invalid Date, Unity Biotechnology (NASDAQ: UBX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Unity Biotechnology's revenue was $0.00.
What was UBX's revenue growth in the past year?
As of Q2 2024, Unity Biotechnology's revenue has grown -100% year over year. This is 242.27 percentage points lower than the US Biotechnology industry revenue growth rate of 142.27%. Unity Biotechnology's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.